ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
16.27
+0.06 (0.37%)
Nov 20, 2024, 4:00 PM EST - Market closed
ACADIA Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 929.24 | 726.44 | 517.24 | 484.15 | 441.76 | 339.08 | Upgrade
|
| Revenue Growth (YoY) | 47.06% | 40.45% | 6.83% | 9.60% | 30.28% | 51.50% | Upgrade
|
| Cost of Revenue | 347.19 | 393.26 | 371.74 | 258.56 | 286.88 | 259.98 | Upgrade
|
| Gross Profit | 582.05 | 333.18 | 145.49 | 225.59 | 154.88 | 79.09 | Upgrade
|
| Selling, General & Admin | 469.81 | 406.56 | 369.09 | 396.03 | 388.66 | 325.64 | Upgrade
|
| Operating Expenses | 469.81 | 406.56 | 369.09 | 396.03 | 388.66 | 325.64 | Upgrade
|
| Operating Income | 112.24 | -73.38 | -223.6 | -170.44 | -233.79 | -246.55 | Upgrade
|
| Interest & Investment Income | 23.21 | 17.23 | 6.61 | 0.59 | 6.61 | 11.17 | Upgrade
|
| EBT Excluding Unusual Items | 131.58 | -56.15 | -216.99 | -169.85 | -227.18 | -235.38 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -52.8 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 5.11 | 5.11 | 3.54 | 2.33 | -1 | 1 | Upgrade
|
| Pretax Income | 136.69 | -51.04 | -213.44 | -167.52 | -280.97 | -234.38 | Upgrade
|
| Income Tax Expense | 8.19 | 10.25 | 2.53 | 0.35 | 0.61 | 0.88 | Upgrade
|
| Net Income | 128.51 | -61.29 | -215.98 | -167.87 | -281.58 | -235.26 | Upgrade
|
| Net Income to Common | 128.51 | -61.29 | -215.98 | -167.87 | -281.58 | -235.26 | Upgrade
|
| Shares Outstanding (Basic) | 165 | 164 | 162 | 160 | 157 | 147 | Upgrade
|
| Shares Outstanding (Diluted) | 166 | 164 | 162 | 160 | 157 | 147 | Upgrade
|
| Shares Change (YoY) | 1.65% | 1.32% | 0.74% | 2.01% | 6.88% | 16.29% | Upgrade
|
| EPS (Basic) | 0.78 | -0.37 | -1.34 | -1.05 | -1.79 | -1.60 | Upgrade
|
| EPS (Diluted) | 0.78 | -0.37 | -1.34 | -1.05 | -1.79 | -1.60 | Upgrade
|
| Free Cash Flow | 202.66 | 16.65 | -114.04 | -126.78 | -143.75 | -152.26 | Upgrade
|
| Free Cash Flow Per Share | 1.22 | 0.10 | -0.71 | -0.79 | -0.91 | -1.03 | Upgrade
|
| Gross Margin | 62.64% | 45.86% | 28.13% | 46.60% | 35.06% | 23.33% | Upgrade
|
| Operating Margin | 12.08% | -10.10% | -43.23% | -35.20% | -52.92% | -72.71% | Upgrade
|
| Profit Margin | 13.83% | -8.44% | -41.76% | -34.67% | -63.74% | -69.38% | Upgrade
|
| Free Cash Flow Margin | 21.81% | 2.29% | -22.05% | -26.19% | -32.54% | -44.90% | Upgrade
|
| EBITDA | 124.54 | -67.83 | -221.57 | -167.1 | -230.85 | -243.78 | Upgrade
|
| EBITDA Margin | 13.40% | -9.34% | -42.84% | -34.51% | -52.26% | -71.89% | Upgrade
|
| D&A For EBITDA | 12.31 | 5.55 | 2.03 | 3.34 | 2.93 | 2.77 | Upgrade
|
| EBIT | 112.24 | -73.38 | -223.6 | -170.44 | -233.79 | -246.55 | Upgrade
|
| EBIT Margin | 12.08% | -10.10% | -43.23% | -35.20% | -52.92% | -72.71% | Upgrade
|
| Revenue as Reported | 929.24 | 726.44 | 517.24 | 484.15 | 441.76 | 339.08 | Upgrade
|
| Advertising Expenses | - | 9.4 | 5.5 | 41.8 | 51.1 | 38.3 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.